Browse > Article
http://dx.doi.org/10.5483/BMBRep.2022.55.7.003

Combination stem cell therapy using dental pulp stem cells and human umbilical vein endothelial cells for critical hindlimb ischemia  

Kim, Chung Kwon (Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University)
Hwang, Ji-Yoon (Medical Innovation Technology Inc. (MEDINNO Inc.))
Hong, Tae Hee (Medical Innovation Technology Inc. (MEDINNO Inc.))
Lee, Du Man (Medical Innovation Technology Inc. (MEDINNO Inc.))
Lee, Kyunghoon (Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University)
Nam, Hyun (Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine)
Joo, Kyeung Min (Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University)
Publication Information
BMB Reports / v.55, no.7, 2022 , pp. 336-341 More about this Journal
Abstract
Narrowing of arteries supplying blood to the limbs provokes critical hindlimb ischemia (CLI). Although CLI results in irreversible sequelae, such as amputation, few therapeutic options induce the formation of new functional blood vessels. Based on the proangiogenic potentials of stem cells, in this study, it was examined whether a combination of dental pulp stem cells (DPSCs) and human umbilical vein endothelial cells (HUVECs) could result in enhanced therapeutic effects of stem cells for CLI compared with those of DPSCs or HUVECs alone. The DPSCs+ HUVECs combination therapy resulted in significantly higher blood flow and lower ischemia damage than DPSCs or HUVECs alone. The improved therapeutic effects in the DPSCs+ HUVECs group were accompanied by a significantly higher number of microvessels in the ischemic tissue than in the other groups. In vitro proliferation and tube formation assay showed that VEGF in the conditioned media of DPSCs induced proliferation and vessel-like tube formation of HUVECs. Altogether, our results demonstrated that the combination of DPSCs and HUVECs had significantly better therapeutic effects on CLI via VEGF-mediated crosstalk. This combinational strategy could be used to develop novel clinical protocols for CLI proangiogenic regenerative treatments.
Keywords
Angiogenesis; Combination; Critical hindlimb ischemia; Dental pulp stem cells; Human umbilical vein endothelial cells;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gupta NK, Armstrong EJ and Parikh SA (2014) The current state of stem cell therapy for peripheral artery disease. Curr Cardiol Rep 16, 447   DOI
2 Liew A and O'Brien T (2012) Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther 3, 28   DOI
3 Ban DX, Ning GZ, Feng SQ et al (2011) Combination of activated Schwann cells with bone mesenchymal stem cells: the best cell strategy for repair after spinal cord injury in rats. Regen Med 6, 707-720   DOI
4 Shi S and Gronthos S (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18, 696-704   DOI
5 Bak S, Ahmad T, Lee YB, Lee JY, Kim EM and Shin H (2016) Delivery of a cell patch of cocultured endothelial cells and smooth muscle cells using thermoresponsive hydrogels for enhanced angiogenesis. Tissue Eng Part A 22, 182-193   DOI
6 Jang S, Collin de l'Hortet A and Soto-Gutierrez A (2019) Induced pluripotent stem cell-derived endothelial cells: overview, current advances, applications, and future directions. Am J Pathol 189, 502-512   DOI
7 Ginsberg M, James D, Ding BS et al (2012) Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFbeta suppression. Cell 151, 559-575   DOI
8 Buckley RH (2004) A historical review of bone marrow transplantation for immunodeficiencies. J Allergy Clin Immunol 113, 793-800   DOI
9 Choi M, Lee HS, Naidansaren P et al (2013) Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol 45, 560-570   DOI
10 Hoch AI, Binder BY, Genetos DC and Leach JK (2012) Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One 7, e35579   DOI
11 Bronckaers A, Hilkens P, Fanton Y et al (2013) Angiogenic properties of human dental pulp stem cells. PLoS One 8, e71104   DOI
12 Leong WK, Henshall TL, Arthur A et al (2012) Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med 1, 177-187   DOI
13 Mamidi MK, Pal R, Dey S et al (2012) Cell therapy in critical limb ischemia: current developments and future progress. Cytotherapy 14, 902-916   DOI
14 Dissanayaka WL, Zhan X, Zhang C, Hargreaves KM, Jin L and Tong EHJJoe (2012) Coculture of dental pulp stem cells with endothelial cells enhances osteo-/odontogenic and angiogenic potential in vitro. 38, 454-463   DOI
15 Dissanayaka WL, Hargreaves KM, Jin L, Samaranayake LP and Zhang CJTEPA (2015) The interplay of dental pulp stem cells and endothelial cells in an injectable peptide hydrogel on angiogenesis and pulp regeneration in vivo. 21, 550-563   DOI
16 Volponi AA, Pang Y and Sharpe PT (2010) Stem cell-based biological tooth repair and regeneration. Trends Cell Biol 20, 715-722   DOI
17 Nam H, Kim GH, Bae YK et al (2017) Angiogenic capacity of dental pulp stem cell regulated by SDF-1alpha-CXCR4 axis. Stem Cells Int 2017, 8085462   DOI
18 Crisan M, Corselli M, Chen WC and Peault B (2012) Perivascular cells for regenerative medicine. J Cell Mol Med 16, 2851-2860   DOI
19 Van Tongeren RB, Hamming JF, Fibbe WE et al (2008) Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino) 49, 51-58
20 Lucitti JL, Mackey JK, Morrison JC, Haigh JJ, Adams RH and Faber JE (2012) Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17. Circ Res 111, 1539-1550   DOI
21 Sprengers RW, Moll FL and Verhaar MC (2010) Stem cell therapy in PAD. Eur J Vasc Endovasc Surg 39 Suppl 1, S38-S43   DOI
22 Farber A, Rosenfield K and Menard M (2014) The BESTCLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia. Tech Vasc Interv Radiol 17, 221-224   DOI
23 Kechagias A, Ylonen K, Kechagias G, Juvonen T and Biancari F (2012) Limits of infrainguinal bypass surgery for critical leg ischemia in high-risk patients (Finnvasc score 3-4). Ann Vasc Surg 26, 213-218   DOI
24 Martin I, De Boer J, Sensebe L and Therapy MSCCotISfC (2016) A relativity concept in mesenchymal stromal cell manufacturing. Cytotherapy 18, 613-620   DOI
25 Al-Khaldi A, Al-Sabti H, Galipeau J and Lachapelle K (2003) Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75, 204-209   DOI
26 Gupta PK, Chullikana A, Parakh R et al (2013) A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med 11, 143   DOI
27 Lee KH, Pyeon HJ, Nam H et al (2018) Significant therapeutic effects of adult human multipotent neural cells on spinal cord injury. Stem Cell Res 31, 71-78   DOI
28 Dissanayaka WL, Hargreaves KM, Jin L, Samaranayake LP and Zhang C (2015) The interplay of dental pulp stem cells and endothelial cells in an injectable peptide hydrogel on angiogenesis and pulp regeneration in vivo. Tissue Eng Part A 21, 550-563   DOI
29 Johannesson A, Larsson GU, Ramstrand N, Turkiewicz A, Wirehn AB and Atroshi I (2009) Incidence of lower-limb amputation in the diabetic and nondiabetic general population: a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations. Diabetes Care 32, 275-280   DOI
30 Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366, 1925-1934   DOI
31 Diez-Tejedor E, Gutierrez-Fernandez M, Martinez-Sanchez P et al (2014) Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. J Stroke Cerebrovasc Dis 23, 2694-2700   DOI
32 Estrela C, Alencar AH, Kitten GT, Vencio EF and Gava E (2011) Mesenchymal stem cells in the dental tissues: perspectives for tissue regeneration. Braz Dent J 22, 91-98   DOI
33 Sakai K, Yamamoto A, Matsubara K et al (2012) Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest 122, 80-90   DOI
34 Reagan-Shaw S, Nihal M and Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22, 659-661   DOI
35 Flugelman MY, Halak M, Yoffe B et al (2017) Phase Ib safety, two-dose study of MultiGeneAngio in patients with chronic critical limb ischemia. Mol Ther 25, 816-825   DOI
36 Griffin M, Greiser U, Barry F, O'Brien T and Ritter T (2010) Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease. Discov Med 9, 219-223
37 Tateishi-Yuyama E, Matsubara H, Murohara T et al (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427-435   DOI
38 Kuroda T, Yasuda S and Sato Y (2013) Tumorigenicity studies for human pluripotent stem cell-derived products. Biol Pharm Bull 36, 189-192   DOI
39 Zhang Y, Liu J, Zou T et al (2021) DPSCs treated by TGF-β1 regulate angiogenic sprouting of three-dimensionally co-cultured HUVECs and DPSCs through VEGF-Ang-Tie2 signaling. Stem Cell Res Ther 12, 281   DOI
40 Vittorio O, Jacchetti E, Pacini S and Cecchini M (2013) Endothelial differentiation of mesenchymal stromal cells: when traditional biology meets mechanotransduction. Integr Biol (Camb) 5, 291-299   DOI